DEC 11, 2017 09:00 AM PST

WEBINAR: Responsible Science: Can you trust your antibody?

SPONSORED BY: Cell Signaling Technology
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Scientific Project Manager, Cell Signaling Technology
    Biography
      Dr. Couvillon has worked at Cell Signaling Technology, Inc. for almost ten years. He joined the company as a product development scientist where he oversaw the validation and release of over 100 different antibody products. Dr. Couvillon also lead a team responsible for the generation of antibodies and kits used for enrichment and analysis of post-translational modifications. He currently works as a special project manager in the marketing group where he is committed to guiding CST's adherence to antibody validation standards and practices. He has been active in attending and presenting at major meetings regarding the topic of antibody reproducibility and works with subject matter experts, antibody users and CST's scientists to ensure that CST continues to lead the field in antibody quality and consistency.
    • Director, Cytometry, Cell Signaling Technology
      Biography
        Dr. Wetzel has been at Cell Signaling Technology for 15 years and currently leads the antibody testing and validation team, the antibody conjugation team, and an assay development team specializing in ELISA, bead assay, and multiplex IHC kits. His areas of expertise include: wide-field, confocal, and spectral fluorescent microscopy, automated high content imaging, flow cytometry, novel dye and conjugation chemistry, and sandwich assay (bead, ELISA, alpha) development.

      Abstract:

      DATE: December 11, 2017
      TIME: 09:00am PST, 12:00pm EST

      Reproducibility is an important and ongoing topic of discussion within the scientific community. Although the reasons underlying the problem are numerous and debatable, this webinar will focus specifically on the impact poorly characterized antibodies have on reproducibility. We will provide guidance for ensuring an antibody is truly binding to the target of interest and show data to demonstrate how alterations to the protocol may affect antibody performance. Our goal is to empower the viewer with technological, process-oriented solutions they can use to employ antibodies confidently in their own work and that will allow them to contribute towards improving the overall reproducibility of the published literature.

       

      Learning Objectives:

      • You will learn how alterations to a protocol may affect antibody performance
      • Guidelines will be offered to ensure an antibody is truly binding to a target of interest

      Show Resources
      You May Also Like
      MAY 24, 2018 09:30 AM PDT
      C.E. CREDITS
      MAY 24, 2018 09:30 AM PDT
      DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
      MAY 22, 2018 08:00 AM PDT
      C.E. CREDITS
      MAY 22, 2018 08:00 AM PDT
      DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
      MAY 02, 2018 08:00 AM PDT
      C.E. CREDITS
      MAY 02, 2018 08:00 AM PDT
      Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
      MAY 24, 2018 09:00 AM PDT
      C.E. CREDITS
      MAY 24, 2018 09:00 AM PDT
      Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
      MAY 29, 2018 09:00 AM PDT
      C.E. CREDITS
      MAY 29, 2018 09:00 AM PDT
      Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
      JUN 20, 2018 10:00 AM EDT
      C.E. CREDITS
      JUN 20, 2018 10:00 AM EDT
      DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
      Loading Comments...